vs
Nixxy, Inc.（NIXX）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Nixxy, Inc.的1.4倍（$69.8M vs $51.1M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -7.8%，领先391.8%），Nixxy, Inc.同比增速更快（10630.2% vs 21.2%），过去两年Nixxy, Inc.的营收复合增速更高（1415.7% vs 53.7%）
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NIXX vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.4倍
$51.1M
营收增速更快
NIXX
高出10609.1%
21.2%
净利率更高
RIGL
高出391.8%
-7.8%
两年增速更快
NIXX
近两年复合增速
53.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $51.1M | $69.8M |
| 净利润 | $-4.0M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -4.1% | 33.2% |
| 净利率 | -7.8% | 384.0% |
| 营收同比 | 10630.2% | 21.2% |
| 净利润同比 | 46.8% | 1769.2% |
| 每股收益（稀释后） | $-0.11 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NIXXRIGL
| Q4 25 | $51.1M | $69.8M | ||
| Q3 25 | $31.9M | $69.5M | ||
| Q2 25 | $13.5M | $101.7M | ||
| Q1 25 | $1.4M | $53.3M | ||
| Q4 24 | $-485.5K | $57.6M | ||
| Q3 24 | $135.9K | $55.3M | ||
| Q2 24 | $133.1K | $36.8M | ||
| Q1 24 | $222.6K | $29.5M |
净利润NIXXRIGL
| Q4 25 | $-4.0M | $268.1M | ||
| Q3 25 | $-2.2M | $27.9M | ||
| Q2 25 | $-4.2M | $59.6M | ||
| Q1 25 | $-4.5M | $11.4M | ||
| Q4 24 | $-7.5M | $14.3M | ||
| Q3 24 | $-13.3M | $12.4M | ||
| Q2 24 | $-1.0M | $-1.0M | ||
| Q1 24 | $-778.4K | $-8.2M |
毛利率NIXXRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | 100.0% | 85.5% | ||
| Q2 24 | 100.0% | 92.4% | ||
| Q1 24 | 98.6% | 93.1% |
营业利润率NIXXRIGL
| Q4 25 | -4.1% | 33.2% | ||
| Q3 25 | -6.8% | 40.9% | ||
| Q2 25 | -20.3% | 60.1% | ||
| Q1 25 | -341.9% | 23.9% | ||
| Q4 24 | 1130.7% | 28.9% | ||
| Q3 24 | -4042.6% | 25.4% | ||
| Q2 24 | -738.7% | 1.2% | ||
| Q1 24 | -473.3% | -23.6% |
净利率NIXXRIGL
| Q4 25 | -7.8% | 384.0% | ||
| Q3 25 | -6.8% | 40.2% | ||
| Q2 25 | -30.9% | 58.6% | ||
| Q1 25 | -325.2% | 21.5% | ||
| Q4 24 | 1542.7% | 24.9% | ||
| Q3 24 | -9795.0% | 22.5% | ||
| Q2 24 | -762.8% | -2.8% | ||
| Q1 24 | -349.8% | -27.9% |
每股收益（稀释后）NIXXRIGL
| Q4 25 | $-0.11 | $14.11 | ||
| Q3 25 | $-0.10 | $1.46 | ||
| Q2 25 | $-0.22 | $3.28 | ||
| Q1 25 | $-0.30 | $0.63 | ||
| Q4 24 | $-0.41 | $0.82 | ||
| Q3 24 | $-2.66 | $0.70 | ||
| Q2 24 | $-0.35 | $-0.06 | ||
| Q1 24 | $-0.40 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $343.0K | $155.0M |
| 总债务越低越好 | $0 | $52.5M |
| 股东权益账面价值 | $8.0M | $391.5M |
| 总资产 | $13.2M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NIXXRIGL
| Q4 25 | $343.0K | $155.0M | ||
| Q3 25 | $30.9K | $137.1M | ||
| Q2 25 | $98.5K | $108.4M | ||
| Q1 25 | $144.1K | $77.1M | ||
| Q4 24 | $142.0K | $77.3M | ||
| Q3 24 | $135.6K | $61.1M | ||
| Q2 24 | $240.3K | $49.1M | ||
| Q1 24 | $273.6K | $49.5M |
总债务NIXXRIGL
| Q4 25 | $0 | $52.5M | ||
| Q3 25 | $0 | $60.0M | ||
| Q2 25 | $1.2M | $60.0M | ||
| Q1 25 | $1.2M | $60.0M | ||
| Q4 24 | $1.2M | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益NIXXRIGL
| Q4 25 | $8.0M | $391.5M | ||
| Q3 25 | $10.4M | $117.6M | ||
| Q2 25 | $6.6M | $81.9M | ||
| Q1 25 | $5.4M | $18.6M | ||
| Q4 24 | $2.6M | $3.3M | ||
| Q3 24 | $6.8M | $-14.6M | ||
| Q2 24 | $2.6M | $-29.9M | ||
| Q1 24 | $3.0M | $-31.7M |
总资产NIXXRIGL
| Q4 25 | $13.2M | $513.6M | ||
| Q3 25 | $16.1M | $242.5M | ||
| Q2 25 | $13.3M | $206.7M | ||
| Q1 25 | $11.8M | $176.0M | ||
| Q4 24 | $7.0M | $164.0M | ||
| Q3 24 | $11.2M | $139.4M | ||
| Q2 24 | $9.8M | $128.4M | ||
| Q1 24 | $10.1M | $126.5M |
负债/权益比NIXXRIGL
| Q4 25 | 0.00× | 0.13× | ||
| Q3 25 | 0.00× | 0.51× | ||
| Q2 25 | 0.18× | 0.73× | ||
| Q1 25 | 0.22× | 3.23× | ||
| Q4 24 | 0.47× | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-516.0K | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NIXXRIGL
| Q4 25 | $-516.0K | $22.0M | ||
| Q3 25 | $-1.0M | $24.0M | ||
| Q2 25 | $-1.2M | $30.5M | ||
| Q1 25 | $-1.8M | $-893.0K | ||
| Q4 24 | $-2.4M | $14.5M | ||
| Q3 24 | $-482.9K | $21.7M | ||
| Q2 24 | $-554.6K | $302.0K | ||
| Q1 24 | $-669.8K | $-5.0M |
现金转化率NIXXRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
